NO20005795D0 - Antiviral compounds - Google Patents

Antiviral compounds

Info

Publication number
NO20005795D0
NO20005795D0 NO20005795A NO20005795A NO20005795D0 NO 20005795 D0 NO20005795 D0 NO 20005795D0 NO 20005795 A NO20005795 A NO 20005795A NO 20005795 A NO20005795 A NO 20005795A NO 20005795 D0 NO20005795 D0 NO 20005795D0
Authority
NO
Norway
Prior art keywords
antiviral compounds
antiviral
compounds
Prior art date
Application number
NO20005795A
Other languages
Norwegian (no)
Other versions
NO20005795L (en
Inventor
Jesus Ezquerra-Carrera
Joseph Michael Gruber
Chafiq Hamdouchi Hamdouchi
Richard Elmer Holmes
Wayne Alfred Spitzer
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20005795D0 publication Critical patent/NO20005795D0/en
Publication of NO20005795L publication Critical patent/NO20005795L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
NO20005795A 1998-05-20 2000-11-16 Antiviral compounds NO20005795L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/010299 WO1999059587A1 (en) 1998-05-20 1998-05-20 Anti-viral compounds

Publications (2)

Publication Number Publication Date
NO20005795D0 true NO20005795D0 (en) 2000-11-16
NO20005795L NO20005795L (en) 2001-01-18

Family

ID=22267098

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005795A NO20005795L (en) 1998-05-20 2000-11-16 Antiviral compounds

Country Status (15)

Country Link
EP (1) EP1077701A4 (en)
JP (1) JP2002515433A (en)
KR (1) KR20010025055A (en)
CN (1) CN1292697A (en)
AU (1) AU7583098A (en)
BR (1) BR9815899A (en)
CA (1) CA2332403A1 (en)
CZ (1) CZ289425B6 (en)
EA (1) EA200001208A1 (en)
HU (1) HUP0102117A2 (en)
IL (1) IL139166A0 (en)
NO (1) NO20005795L (en)
SK (1) SK17482000A3 (en)
TR (1) TR200003414T2 (en)
WO (1) WO1999059587A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR213700A0 (en) * 2000-12-18 2001-01-25 Biota Scientific Management Pty Ltd Antiviral agents
AR048650A1 (en) * 2004-05-04 2006-05-10 Tibotec Pharm Ltd DERIVATIVES OF (1,10B-DIHIDRO-2- (AMINOCARBONIL-PHENYL) -5H-PIRAZOLO [1,5 C] [1,3] BENZOXAZIN-5-IL) METHANONE PHENYL AS INHIBITORS OF HIV VIRAL REPLICATION
ATE462697T1 (en) 2004-08-12 2010-04-15 Amgen Inc BISARYL SULFONAMIDES
AR056187A1 (en) * 2005-03-21 2007-09-26 S Bio Pte Ltd IMIDAZO DERIVATIVES [1,2-A) PIRIDINE: PREPARATION, PHARMACEUTICAL COMPOSITIONS AND USE TO PREPARE MEDICATIONS
US7666880B2 (en) 2005-03-21 2010-02-23 S*Bio Pte Ltd. Imidazo[1,2-A]pyridine derivatives: preparation and pharmaceutical applications
US7910595B2 (en) 2005-12-21 2011-03-22 Abbott Laboratories Anti-viral compounds
WO2007081517A2 (en) 2005-12-21 2007-07-19 Abbott Laboratories Anti-viral compounds
ATE475660T1 (en) 2005-12-21 2010-08-15 Abbott Lab ANTIVIRAL COMPOUNDS
WO2008133753A2 (en) 2006-12-20 2008-11-06 Abbott Laboratories Anti-viral compounds
JP5469662B2 (en) * 2008-05-27 2014-04-16 バイオウタ サイエンティフィック マネジメント プロプライエタリー リミテッド Antiviral salt
US8546405B2 (en) 2008-12-23 2013-10-01 Abbott Laboratories Anti-viral compounds
ES2567047T3 (en) 2008-12-23 2016-04-19 Abbvie Inc. Anti-viral pyrimidine derivatives
SG175144A1 (en) * 2009-04-15 2011-11-28 Abbott Lab Anti-viral compounds
WO2014060381A1 (en) 2012-10-18 2014-04-24 Bayer Cropscience Ag Heterocyclic compounds as pesticides
WO2014067962A1 (en) 2012-10-31 2014-05-08 Bayer Cropscience Ag Novel heterocyclic compounds as pest control agents
CN104370732B (en) * 2014-01-26 2015-08-19 山东信立泰药业有限公司 The preparation method of a kind of clopidogrel and intermediate thereof
CN109535405B (en) * 2017-09-21 2021-07-30 宁波聚嘉新材料科技有限公司 Preparation method of polyarylate based on 2- (4-carboxyphenyl) -5-hydroxypyridoimidazole
CN109810085B (en) * 2019-04-19 2019-07-19 上海皓元生物医药科技有限公司 The preparation method of ACC inhibitor and its intermediate
CN110746450A (en) * 2019-09-17 2020-02-04 济南康和医药科技有限公司 Synthetic method of beraprost sodium key intermediate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4096264A (en) * 1975-12-09 1978-06-20 Merck & Co., Inc. Certain substituted imidazo [1,2-a] pyridines
US4250174A (en) * 1979-05-02 1981-02-10 Merck & Co., Inc. 3-Substituted imidazo [1,2-A] pyridines
US5693661A (en) * 1995-06-07 1997-12-02 Eli Lilly And Company Anti-viral compounds
KR20000016346A (en) * 1996-06-05 2000-03-25 피터 지. 스트링거 Antiviral compounds
US5891874A (en) * 1996-06-05 1999-04-06 Eli Lilly And Company Anti-viral compound
US5821242A (en) * 1996-06-06 1998-10-13 Eli Lilly And Company Anti-viral compounds

Also Published As

Publication number Publication date
AU7583098A (en) 1999-12-06
CZ20004278A3 (en) 2001-05-16
KR20010025055A (en) 2001-03-26
IL139166A0 (en) 2001-11-25
JP2002515433A (en) 2002-05-28
EP1077701A1 (en) 2001-02-28
BR9815899A (en) 2001-02-20
HUP0102117A2 (en) 2001-12-28
EP1077701A4 (en) 2002-03-20
EA200001208A1 (en) 2001-06-25
CN1292697A (en) 2001-04-25
CA2332403A1 (en) 1999-11-25
WO1999059587A1 (en) 1999-11-25
TR200003414T2 (en) 2001-03-21
NO20005795L (en) 2001-01-18
SK17482000A3 (en) 2005-03-04
CZ289425B6 (en) 2002-01-16

Similar Documents

Publication Publication Date Title
NO20010047D0 (en) Antiviral macrocyclic compounds
BR9709643A (en) Antiviral compounds
LTPA2009006I1 (en) THROMBOPOETINE COMPOUNDS
ATE229954T1 (en) BETACARBOLINE COMPOUNDS
ID28266A (en) AMIDIN COMPOUNDS
DK1070058T3 (en) (4-Arylsulfonylamino) tetrahydropyran-4-carboxylsyrehydroxamider
NO20011745L (en) compounds
NO20006520D0 (en) adenosine
ID23761A (en) SUBSTITUTED TRISICLIC
DE69926033D1 (en) Schlüsselkodekorrelationsanordnung
NO20005795D0 (en) Antiviral compounds
NO20005006L (en) Calcilitic compounds
ID23219A (en) SUBSTITUTED TRISICLIC
NO20006662D0 (en) Fluorfenylresin compounds
BR9709432A (en) Antiviral Compounds
NO20011358L (en) Antiviral combinations
DK1054867T3 (en) Antiviral agents
BR9709528A (en) Antiviral compounds
PT1076660E (en) (4-BROMOPYRAZOL-3-YL) -BZZAZOLES
DE59912188D1 (en) SUBSTITUTED PHENYLURACILE
ATE303996T1 (en) SUBSTITUTED ACYLAMINOPHENYL URACILES
DE59911610D1 (en) SUBSTITUTED BENZOYLCYCLOHEXANDIONE
ATA126298A (en) VERPUFFUNGSKLAPPE
SE9600614D0 (en) Antiviral compounds
SE9602566D0 (en) Antiviral compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application